BPC-157

Preclinical Only

Also known as: Body Protection Compound 157

Synthetic pentadecapeptide

How it works: A synthetic peptide derived from a sequence found in gastric juice, studied in animal models for tissue-repair-related pathways. Human clinical data are essentially absent and it is not FDA-approved.
Known risks: Human safety is not established; evidence is limited to animal and laboratory studies. Quality and purity of compounded products vary.
Contraindications: No established human use; not recommended outside research contexts.
Drug interactions: Unknown in humans.

Citations

Stable Gastric Pentadecapeptide BPC 157: review of preclinical research (2018) · PMID 29345579

This information is educational only and is not medical advice. A licensed provider makes all clinical decisions. Diadara provides no dosing, reconstitution, or administration guidance.

BPC-157 is provided here for education only — it is not currently offered through Diadara. See what we do offer →